Skip to content

Stock-Based Comp at other companies

Merck & Co. logo
Merck & Co.MRK
$185M-5.1%
Zoetis logo
ZoetisZTS
$25M+47.1%
Idexx Laboratories logo
Idexx LaboratoriesIDXX
$16.34M+11.8%
Tractor Supply Company logo
Tractor Supply CompanyTSCO
$17.63M+33.3%
Kenvue logo
KenvueKVUE
$29M-34.1%
General Mills logo
General MillsGIS
$26.3M+28.3%

Other financials

Income statement

See full
Revenue$1.4B+14.9%
Gross profit$785.0M+14.8%
Net income$57.0M-14.9%
EPS (diluted)$0.11-15.4%

Balance sheet

See full
Cash & equivalents$428.0M-12.1%
Total debt$4.3B-1.7%
Total equity$6.5B+2.3%
Total assets$13.2B+2.2%

Cash flow

See full
Operating cash flow$13.0M+425%
CapEx$51.0M-21.5%
Free cash flow-$38.0M+44.9%

Valuation

See full
Market cap$12.1B+128%
Enterprise value$15.99B+73.1%
P/S2.5×+1.3×

Profitability

See full
Gross margin55.1%+0.2pp
Net margin-4.9%-13.6pp
FCF margin6.4%-1.4pp

Returns & leverage

See full
Return on equity-3.8%-9.9pp
Debt / equity0.7×0.0×
Current ratio2.2×-0.6×

Where this comes from

Reported directly by Elanco Animal Health Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Elanco Animal Health Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Elanco Animal Health Inc.'s stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Elanco Animal Health Inc.'s stock-based comp?
Elanco Animal Health Inc. (ELAN) reported stock-based comp of $21M in Q1 2026.
How has Elanco Animal Health Inc.'s stock-based comp changed year-over-year?
Elanco Animal Health Inc.'s stock-based comp increased by 40.0% year-over-year, from $15M to $21M.
What is the long-term trend for Elanco Animal Health Inc.'s stock-based comp?
Over 4 years (2021 to 2025), Elanco Animal Health Inc.'s stock-based comp has grown at a 0.7% compound annual growth rate (CAGR), from $66M to $68M.
What does stock-based comp mean?
The non-cash cost of paying employees with company stock instead of cash.
How do you interpret stock-based comp?
Higher values suggest aggressive equity-based incentive programs, which may lead to shareholder dilution.
How does stock-based comp compare across companies?
Common in growth-oriented and large-cap companies; investors compare this to total revenue to assess compensation intensity.